Placeholder Image

字幕列表 影片播放

  • welcome to another MedCram coronavirus update so let's go to the numbers again

  • these are numbers that we take with a grain of salt these are the numbers that

  • we have they are coming from the w-h-o who has been allowed into China as of

  • yesterday also from the CDC here we know that these numbers are probably

  • underestimated we know that because only the most severe cases that made to the

  • hospital are getting tested

  • we know that these numbers are under don't know by how much we may never know

  • how much total deaths keep increasing by bigger numbers 1018 total recovered is

  • growing probably the fastest okay let's go over to our other website that we

  • look at which is the worldA meter at least according to these numbers there

  • is a suggestion that things are layering out let's go back though to our death

  • cases that doesn't seem to be at all petering out in fact if we look at the

  • number of deaths here February 10th deaths total was 108 and

  • that seems to indicate what we've been talking about all along and that is the

  • number of cases usually represents something earlier in the course and that

  • takes time for the patient to get sick to the point of death which takes a

  • little bit longer so hopefully here in the next week or so

  • we might start to see death starting to layer out we can only hope that that's

  • the case we know that almost all of these deaths are happening in mainland

  • China in the wuhan area of course their system as with any system is overwhelmed

  • inundated and things that would normally be happening or not happening as they

  • should they are trying to alleviate that by building hospitals dedicated to

  • taking care of these more milder symptoms so they can take the stress off

  • of the hospitals to take care of these more severe cases so of course the big

  • news over the last 24 hours has been about the incubation period we're gonna

  • get to what to make about incubation period of 24 days before we get to that

  • the other big news is San Diego California just got its first case and

  • interestingly it was from four people that were hospitalized because of

  • symptoms at UC San Diego and they had done some testing there at UC San Diego

  • apparently went to the CDC and the CDC released them but one of these people

  • actually had further testing done and it turned out to be positive in which case

  • that patient came right back to the hospital and they had quarantined them

  • and everyone's doing well it's just that we have a patient that's turned positive

  • and so again these are people that flew in last Wednesday from China and are

  • being quarantined at the Miramar base just north of San Diego so let's talk

  • about this quarantine issue actually the quarantine issue which is related to the

  • incubation period so up to this point was felt that 14 days was enough to take

  • care of any potential type of infection in fact that's where the recommendation

  • came for just about anyone in the world now that is coming from China they are

  • quarantine them because the incubation period is about 14 days well there was

  • this new paper that was published pre peer-reviewed what does that mean that

  • means that before a bunch of scientists that are in that field got to look at

  • the paper pick it apart and say hey what about this what about that it got

  • published on a server and it's out there let's talk about it so here is the

  • article the lead author whose name actually goes at the end is this

  • gentleman nan Xiang Zhang this is a pulmonologist and you know I've got a

  • soft spot in my heart for pulmonologist because I am one and here's the abstract

  • for it and then here's the key part it says the median incubation period was

  • three days range of 0 to 24 point 0 days and of course they went into a lot of

  • other things so some things I want to point out here which is really

  • interesting is if you were to see our update from yesterday where we actually

  • quoted the Jama article the Jama article was a publication that looked at a

  • hundred and thirty-eight patients that were seen in the hospital there in Wuhan

  • this one actually looks at 1099 patients so you're gonna get a much bigger n

  • number that was at one hospital this is at five hundred and fifty two hospitals

  • in 31 provinces through January 29 2020 so here the meeting age as compared to

  • the JAMA article was a little bit younger that was in the 50s this one's

  • 47 years of age in this case there was a bigger majority that were males in the

  • previous one it was more split half and a half we saw about the same number of

  • people with fever people with cough we also saw that

  • diarrhea was uncommon but it did happen but there's some other interesting

  • things we saw that lymphopenia that means low white blood cells were

  • observed that seems to a very common finding in any type of

  • viral infection but in the jam article which was looking at 138 patients in a

  • single Medical Center in that situation there were 36 patients or 26% that were

  • admitted to the intensive care unit here only 55 patients or 5% were admitted to

  • the intensive care unit let me explain that again the larger study that had

  • more patients in it and was more of a cross-section of the area had a much

  • lower admission rate to the intensive care unit only 5% and whereas in our jam

  • article 4.3 percent died at least at the time of publication the mortality rate

  • here in this publication was only one point three six percent so seems as

  • though the patients included in this study were not as severe so what do we

  • say about this 24 days let's talk about that the first thing you need to look at

  • is that the median incubation period was 3.0 days and so what that means is that

  • this 24 days was a real outlier so what would make that outlier exists well they

  • asked the w-h-o doctor at a press conference on the 10th that very same

  • question and the response was that sometimes what can happen is there is a

  • reinfection later on that makes the exposure look longer than it really is

  • in fact they've seen this in Ebola where there is a double exposure and sometimes

  • what can happen is there is a reinfection later on that makes the

  • incubation period look longer than it really is so what we mean to say there

  • there's an infection that occurs here on day zero and then there's an incubation

  • period here of let's say 10 days incubation period and then there's

  • another repeated one and this one may not cause symptoms but this repeated one

  • may cause symptoms and that will be another incubation period and then let's

  • say this one happens to be 14 days and then symptoms occur and so they can

  • clearly identify this as one of the potential infection periods and they

  • look at this of course as the symptoms what they don't

  • realize though is that there is another infection that occurred and that the

  • total when added up yes it comes out to 24 days but that's not the incubation

  • period of this infection to this symptom there is another one there it's an

  • interesting concept this is an outlier and so sometimes you will get outliers

  • right there is always a bell-shaped distribution with most things that is

  • anyway and so yes is it possible that you're gonna get an outlier here at the

  • 99th percentile or the first percentile it's possible but it seems as though at

  • least at this point what we're talking about in terms of a median is three days

  • on the incubation period what we'll do is we'll put a link in to the video

  • where the reporter asks the w-h-o physician about exactly what does this

  • 24 day incubation period mean okay so let's talk a little bit more about

  • what's happening and what it is that we can do so we spent some time if you look

  • at our previous videos talking about things that we can do to help us prevent

  • getting the virus and that's what a lot of expenditure is going into right now

  • quarantine shutting down but we've also talked

  • about what is the treatment that can occur if somebody actually comes down

  • with the corona virus and they have symptoms that are severe enough that end

  • them up in the hospital we've already talked a little about some of the

  • medications and we'll talk more about some of these medications that are being

  • used realize that medications that are used for diseases at least in the United

  • States or in Europe have to go through rigorous placebo controlled trials for

  • them to be indicated for that so in other words if you have a blood pressure

  • medication or you have an antibiotic it has to be tested for that particular

  • indication for it to work now we can't do this with a brand new corona virus we

  • will never have randomized placebo-controlled trials ready to go at

  • the initiation of an outbreak they are planning to have something maybe in

  • April and that's really really fast for some of these medications but we don't

  • have anything that we know is going to work and so as a result of that whenever

  • we give something for treatment unless it's a known

  • situation like ARDS because viral pneumonia can cause a RDS that's acute

  • respiratory distress syndrome there are some treatments that we know work we've

  • talked about this in our video which will give you a link to how corona virus

  • kills there's something that we can do called prone positioning there's

  • something that we can do called paralysis and there's also something

  • called low tidal volumes so all of these are things that we can do to help

  • improve because that's been a randomized placebo-controlled trial for a RDS but

  • in terms of medications for this corona virus we don't have it practical things

  • that we can do we don't have randomized placebo-controlled trials which are the

  • best evidence for these things so what do we do instead we look at the biology

  • of things and we make certain choices and we say yes even though we know that

  • we don't know for sure if this is going to work we're still going to try it

  • anyway because there's very little risk so for instance for medications that

  • have indications for other diseases for instance HIV it may work in coronavirus

  • and so what we'll do is we'll do this and it's called the compassionate use

  • compassionate use and you have to apply for that to use it and so that's what

  • happened in this case in the gentleman in Thailand where they used medications

  • that were typically indicated for HIV they used it to see if the man would get

  • better and that's the kind of things that we have now basically anything that

  • we say we're going to throw at in terms of a medication against coronavirus it's

  • going to be compassionate use we're not going to have the best evidence to say

  • it's going to work so what I would like to do over the next couple of videos and

  • we've talked about this before is to look at some practical things that the

  • biology tells us may work but can I tell you for sure that it's going to help you

  • know so what are those things they're things that'll fit into the category

  • where there is question about very low risk these are the kinds of things that

  • you can concentrate on to help you if you are ever in the situation where you

  • have corona virus what is it that you can do beforehand and at the point of to

  • limit the morbidity and mortality and I'm telling you right now you're going

  • to be surprised at some of the things but I'm gonna show you the evidence for

  • it and you may say no really could that really help me well we'll go over the

  • evidence and you make your pre final decision and if the benefits outweigh

  • the risks then you should do it thanks for joining us

welcome to another MedCram coronavirus update so let's go to the numbers again

字幕與單字

單字即點即查 點擊單字可以查詢單字解釋